This paper discusses recent world trends in the treatment of Wilms' tumour, particularly as exemplified by their impact on practice at the Royal Children's Hospital, Melbourne.
Following the use of actinomycin D in the therapy of lung metastases of Wilms' tumour (see below), it became apparent that this drug was able, at times, to inhibit their growth and, more rarely, to cause their complete regression.
In order to examine the merits of putting the drug to more general use in the treatment of this malignancy, a meeting of those interested was held at the Royal Children's Hospital on April 15, 1959. Examination of records indicated that, since the introduction of post-operative irradiation of the tumour bed, death from Wilms' tumour was largely the result of blood-stream dissemination. Nevertheless, as adduced by the author in 1957, in a review of 26 consecutive cases, the recovery rate was still only 11.50%.
In view of the proved effect of actinomycin D on established lung metastases it was considered that if nephrectomy were performed under its cover haematogenous dissemination might be eliminated and any minimal undetectable metastases already present be suppressed.
Accordingly the following three decisions were taken.
(1) That actinomycin D be introduced into the treatment sequence; (2) that the drug be pushed to the limits of tolerance; and (3) that tumour bed irradiation be deferred for a limited period in order to avoid the simultaneous action of two bone marrow depressants.
The following plan was conceived and enunciated in terms of days of treatment.
Actinomycin D was administered in a total dosage of 120 ,ug./kg., divided into 8 equal injections to be * A paper read at a meeting of the British Association of Paediatric Surgeons in Rotterdam, September 1964. given on Days 1, 2, 3, 4, 5, 7, 9,  The toxic effects are manifest in relation to (a) the bone marrow, where the activity is depressed even to the point of aplastic anaemia; (b) the skin and its appendages, causing macular rashes and epilation of the hair of the scalp; and (c) the gastro-intestinal tract, as instanced by anorexia, vomiting, ulcerative stomatitis, and diarrhoea (often blood-stained).
There have been two instances (Case 15 and a subsequent case too recent for inclusion in this series) of the development, 2 weeks after cessation of radiotherapy, of oedema of the extremities and ascites with marked liver and splenic enlargement: in both the tumour was in the right kidney. It is suggested that the effect of irradiation on the liver was potentiated by the previous action of actinomycin D with resultant swelling and portal obstruction. Investigations on Case 15 showed that there was no obstruction of inferior vena cava or hepatic veins (as determined by catheterization) but that the serum protein level had fallen to 5 g./100 ml., with decrease in the albumin fraction, accounting for the generalized oedema. The ascitic fluid was milky in appearance but proved unsatisfactory for cell examination owing to precipitation of lipid material.
The second case (a recent one) presented a similar picture. Both recovered on supportive treatment only, liver and spleen returning to normal size over a period of 4 months.
In an even more recent case (still undergoing irradiation), on the eighth day after starting treatment, acute intussusception occurred in the lower ileum, demanding bowel resection. The bowel in the region of the apex of the intussusception displayed several swollen areas with central ulceration. Though specific pathological proof is lacking, it seems logical to place this occurrence in sequence with the well-known manifestation of blood-stained diarrhoea, and to class it as a further complication, hitherto unlisted, of actinomycin D administration (the child also exhibited skin lesions and stomatitis). 
